These images are provided for non-commercial use under a Creative Commons License (BY-NC-ND). To license a high resolution version, please contact our image library who will discuss fees, terms and waivers.
Download this imageCreative commons explained - what it means, how you can use our's and other people's content.
Temple of 'Minerva Medica', Rome
Draughtsman: Busiri, Giovanni Battista
History note: General Sir George Cockburn; Shanganagh Library; Spencer George Perceval
Height: 222 mm
Width: 166 mm
Method of acquisition: Bequeathed (1922) by Perceval, Spencer George
Busiri Vici, p. 95, pl. 88. A gouache drawing of the Temple of 'Minerva Medica', shown the other side, is at Felbrigg Hall, Norwich.
Support composed of paper
Drawing : Pen and brown ink on paper
Accession number: 3693 f.27
Primary reference Number: 9798
Stable URI
Owner or interested party:
The Fitzwilliam Museum
Associated department:
Paintings, Drawings and Prints
This record can be cited in the Harvard Bibliographic style using the text below:
The Fitzwilliam Museum (2024) "Temple of 'Minerva Medica', Rome" Web page available at: https://data.fitzmuseum.cam.ac.uk/id/object/9798 Accessed: 2024-11-26 08:07:13
To cite this record on Wikipedia you can use this code snippet:
{{cite web|url=https://data.fitzmuseum.cam.ac.uk/id/object/9798
|title=Temple of 'Minerva Medica', Rome
|author=The Fitzwilliam Museum|accessdate=2024-11-26 08:07:13|publisher=The
University of Cambridge}}
To call these data via our API (remember this needs to be authenticated) you can use this code snippet:
https://data.fitzmuseum.cam.ac.uk/api/v1/objects/object-9798
To use this as a simple code embed, copy this string:
<div class="text-center">
<figure class="figure">
<img src="https://data.fitzmuseum.cam.ac.uk/imagestore/pdp/pdp38/3693_20f_27.jpg"
alt="Temple of 'Minerva Medica', Rome"
class="img-fluid" />
<figcaption class="figure-caption text-info">Temple of 'Minerva Medica', Rome</figcaption>
</figure>
</div>
Updates about future exhibitions and displays, family activities, virtual events & news. You'll be the first to know...
